[1]BEATSON GT.Classics in oncology:On the treatment of inoperable cases of carcinoma of the mamma:suggestions for a new method of treatment,with illustrative cases[J].Lancet,1989,2(3803):162-165.
[2]CHIAPPA C,ROVERA F,RAUSEI S,et al.Breast cancer and thyroid diseases:analysis of 867 consecutive cases[J].Journal of Endocrinological Investigation,2017,40(2):179-184.
[3] DOBRINJA C,SCOMERSI S,GIUDICI F,et al.Association between benign thyroid disease and breast cancer:a single center experience[J].BMC Endocr Disord,2019,19(1):104.
[4]HUANG NS,CHEN XX,WEI WJ,et al.Association between breast cancer and thyroid cancer:A study based on 13978 patients with breast cancer[J].Cancer Medicine,2018,7(12):6393-6400.
[5]PRINZI N,BALDINI E,SORRENTI S,et al.Prevalence of breast cancer in thyroid diseases:results of a cross-sectional study of 3921 patients[J].Breast Cancer Research & Treatment,2014,144(3):683-688.
[6]SGAARD M,FARKAS DK,EHRENSTEIN V,et al.Hypothyroidism and hyperthyroidism and breast cancer risk:a nationwide cohort study[J].European Journal of Endocrinology,2016,174(4):409-414.
[7]JISKRA J,LíMANOVá Z,BARKMANOVá J,et al.Autoimmune thyroid diseases in women with breast cancer and colorectal cancer[J].Physiological Research,2004,53(6):693-702.
[8]GOGAS J,KOUSKOS E,TSELENI-BALAFOUTA S,et al.Autoimmune thyroid disease in women with breast carcinoma[J].Eur J Surg Oncol,2001,27(7):626-630.
[9]SHI YL,LI X,RAN L,et al.Study on the status of thyroid function and thyroid nodules in chinese breast cancer patients[J].Oncotarget,2017,8(46):80820-80825.
[10] AN JH,HWANGBO Y,AHN HY,et al.A possible association between thyroid cancer and breast cancer[J].Thyroid:Official Journal of the American Thyroid Association,2015,25(12):1330-1338.
[11]KIM EY,CHANG Y,LEE KH,et al.Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk:A cohort study[J].Int J Cancer,2019,145(12):3257-3266.
[12]HERCBERGS A,MOUSA SA,LEINUNG M,et al.Thyroid hormone in the clinic and breast cancer[J].Horm Cancer,2018,9(3):139-143.
[13]CENGIZ O,BOZKURT B,UNAL B,et al.The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women[J].Journal of Surgical Oncology,2004,87(1):19-25.
[14]CRISTOFANILLI M,YAMAMURA Y,KAU SW,et al.Thyroid hormone and breast carcinoma:Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma[J].Cancer,2005,103(6):1122-1128.
[15]GONZáLEZ-SANCHO JM,FIGUEROA A,LóPEZ-BARAHONA M,et al.Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells[J].Molecular Carcinogenesis,2002,34(1):25-34.
[16]HUANG J,JIN L,JI G,et al.Implication from thyroid function decreasing during chemotherapy in breast cancer patients:chemosensitization role of triiodothyronine[J].BMC Cancer,2013,13(1):334.
[17]田甜,张淑群.甲状腺激素及其受体与乳腺癌的关系[J].现代肿瘤医学,2016,24(9):1483-1486.
TIAN T,ZHANG SQ.The relationship between thyroid hormone,thyroid hormone receptors and breast cancer[J].Modern Oncology,2016,24(9):1483-1486.
[18]FIGUEIREDO NB,CESTARI SH,CONDE SJ,et al.Estrogen-responsive genes overlap with triiodothyronine-responsive genes in a breast carcinoma cell line[J].The Scientific World Journal,2014(2014):1-7.
[19]CESTARI SH,FIGUEIREDO NB,CONDE SJ,et al.Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors[J].Arq Bras Endocrinol Metabol,2009,53(7):859-864.
[20]TOSOVIC A,BECKER C,BONDESON AG,et al.Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk[J].Int J Cancer,2012,131(9):2126-2133.
[21]BRANDT J,BORGQUIST S,MANJER J.Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups:a malm diet and cancer study[J].Cancer Causes Control,2015,26(8):1093-1104.
[22]KUIJPENS JL,NYKLICTEK I,LEUWMAN MW,et al.Hypothyroidism might be related to breast cancer in postmenopausal women[J].Thyroid,2005,15(11):1253-1259.
[23]GU G,GELSOMINO L,COVINGTON KR,et al.Targeting thyroid hormone receptor beta in triple-negative breast cancer[J].Breast Cancer Research and Treatment,2015,150(3):535-545.
[24]KRESS E,SAMARUT J,PLATEROTI M.Thyroid hormones and the control of cell proliferation or cell differentiation:paradox or duality[J].Molecular & Cellular Endocrinology,2009,313(1/2):36-49.
[25]MARTíNEZ-IGLESIAS O,GARCIA-SILVA S,TENBAUM SP,et al.Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis[J].Cancer Research,2009,69(2):501-509.
[26] PARK JW,ZHAO L,WILLINGHAM M,et al.Oncogenic mutations of thyroid hormone receptor β[J].Oncotarget,2015,6(10):8115-8131.
[27]LóPEZ-FONTANA CM,SASSO CV,MASELLI ME,et al.Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors[J].Oncol Rep,2013,30(4):1651-1660.
[28]DITSCH N,TOTH B,HIMSL I,et al.Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancer[J].Histol Histopathol,2013,28(2):227-37.
[29]VILLA NATALIE M,LI N,YEH MW,et al.Serum thyrotropin concentrations are not predictive of aggressive breast cancer biology in euthyroid individuals[J].Endocr Pract,2015,21(9):1040-1045.
[30] KHAN SR,CHAKER L,RUITER R,et al.Thyroid function and cancer risk:The rotterdam study[J].J Clin Endocrinol Metab,2016,101(12):5030-5036.
[31]MOUROUZIS I,TZOVARAS A,ARMONIS B,et al.Are thyroid hormone and tumor cell proliferation in human breast cancers positive for HER2 associated[J].Int J Endocrinol,2015,2015:1-6.
[32]BRANDT J,BORGQUIST S,ALMQUIST M,et al.Thyroid function and survival following breast cancer[J].British Journal of Surgery,2016,103(12):1649-1657.
[33]SZYCHTA P,SZYCHTA W,GESING A,et al.TSH receptor antibodies have predictive value for breast cancer-retrospective analysis[J].Thyroid Research,2013,6(1):8.
[34]HARDEFELDT PJ,ESLICK GD,EDIRIMANNE S.Benign thyroid disease is associated with breast cancer:a meta-analysis[J].Breast Cancer Research & Treatment,2012,133(3):1169-1177.
[35]DRUGARIN D,NEGRU S,KORECK A,et al.The pattern of a T(H)1 cytokine in autoimmune thyroiditis[J].Immunology Letters,2000,71(2):73-77.
[36]CHYAN A,CHEN J,SHUGARD E,et al.Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy[J].Radiation Oncology,2014,9(1):269.
[37]MULLER I,GIANI C,ZHANG L,et al.Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer[J].International Journal of Cancer,2014,134(7):1706-1714.
[38]FARAHATI J,ROGGENBUCK D,GILMAN E,et al.Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer[J].Clin Chem Lab Med,2012,50(4):709-714.
[39]DERWAHL M,NICULA D.Estrogen and its role in thyroid cancer[J].Endocr Relat Cancer,2014,21(5):T273-T283.
[40]FARIA CC,PEIXOTO MS,CARVALHO DP,et al.The emerging role of estrogens in thyroid redox homeostasis and carcinogenesis[J].Oxid Med Cell Longev,2019,2019:1-13.
[41]SANTIN AP,FURLANETTO TW.Role of estrogen in thyroid function and growth regulation[J].Journal of Thyroid Research,2011,2011:1-7.
[42]KANSAKAR E,CHANG YJ,MEHRABI M,et al.Expression of estrogen receptor,progesterone receptor,and vascular endothelial growth factor-A in thyroid cancer[J].American Surgeon,2009,75(9):785-789.
[43]RAJORIA S,SURIANO R,SHANMUGAM A,et al.Metastatic phenotype is regulated by estrogen in thyroid cells[J].Thyroid,2010,20(1):33-41.
[44]ZIMMERMANN MB.Thyroid gland:Iodine deficiency and thyroid nodules[J].Nat Rev Endocrinol,2014,10(251):707-708.
[45]O'KANE SM,MULHERN MS,POURSHAHIDI LK,et al.Micronutrients,iodine status and concentrations of thyroid hormones:a systematic review[J].Nutr Rev,2018,76(6):418-431.
[46]SHI XZ,XUE L,JIN X,et al.Different expression of sodium-iodide importer (NIS) between lactating breast and thyroid tissues may be due to structural difference of thyroid-stimulating hormone receptor (TSHR)[J].Journal of Endocrinological Investigation,2017,40(1):41-48.
[47]ACEVES C,GARCíA-SOLíS P,ARROYO-HELGUERA O,et al.Antineoplastic effect of iodine in mammary cancer:participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)[J].Molecular Cancer,2009,8(1):33.
[48] ARROYO-HELGUERA O,ROJAS E,DELGADO G,et al.Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells:evidence that 6-iodolactone mediates apoptotic effects[J].Endocrine-Related Cancer,2008,15(4):1003-1011.
[49]韩俊庆,俞新爽,刘奇.甲状腺疾病与乳腺癌的关系[J].实用肿瘤学杂志,2008,22(1):63-65.
HAN JQ,YU XS,LIU Q.Relationship between thyroid disease and breast cancer[J].Practical Oncology Journal,2008,22(1):63-65.